2013 Q4/Global Life Sciences


Summary

Full results


Rank Chg Organisation name Overall
1 +0 Idenix Pharmaceuticals
8.4
2 +0 Kyowa Hakko Kirin UK
7.9
3 +7 Kyorin Holdings
7.4
4 +1 Mylan UK
7.2
5 +6 Biotecnol
7.1
6 -3 Wockhardt
6.9
7 +0 Galenica AG
6.9
8 +7 Kaken Pharmaceutical
6.7
9 +26 Taisho Pharmaceutical
6.6
10 -4 EISAI UK
6.6
11 +12 Yakult UK
6.5
12 -4 Debiopharm
6.5
13 -1 Servier UK
6.5
14 -5 Genmab
6.4
15 -2 Actelion UK
6.4
16 -12 Renovo
6.3
17 +0 Vectura
6.2
18 -2 ImmunoGen
6.1
19 -1 Lilly UK
6.0
20 -6 Aptalis Pharma
6.0
21 +3 KRKA
6.0
22 +25 Zandu
6.0
23 -1 Meda Pharmaceuticals
5.9
24 +1 Otsuka Pharmaceuticals Europe
5.9
25 +27 MorphoSys
5.7
26 +7 Galapagos
5.7
27 -1 EISAI
5.7
28 +3 Recordati
5.6
29 +45 Bayer Schering Pharma
5.5
30 -1 Otsuka Pharmaceuticals
5.4
31 +1 Dusa Pharmaceuticals
5.3
32 +16 Dainippon Sumitomo
5.2
33 +17 Nektar Therapeutics
5.2
34 +93 QLT
5.2
35 +1 Astellas Europe
5.2
36 -2 Wockhardt UK
5.2
37 +0 Stallergenes
5.1
38 +0 Santen
5.1
39 -12 Pfizer UK
5.1
40 +0 Daiichi-Sankyo UK
5.1
41 +2 Valeant Pharmaceuticals
5.0
42 -3 Sanofi UK
5.0
43 -13 Astrazeneca Uk
5.0
44 +14 Laboratoires Thea
4.9
45 +1 Covence
4.9
46 +5 Fresenius Medical Care
4.9
47 +57 Alkaloid
4.9
48 -20 AEterna Zentaris
4.9
49 +16 Roche
4.8
50 -8 MediGene
4.8


Changes in rank are compared to 2013 Q3/Global Life Sciences. Since then, 3 sites entered the survey and 48 sites could not be included in the rankings (2 fewer since last time). Build your own. Report statistics.